Experts question long-term efficacy of Abilify for bipolar disorder - Related Stories - AANP SmartBrief
Links shared publicly online about this topic.
- 317total visits
Experts question long-term efficacy of Abilify for bipolar disorder - Related Stories - AANP SmartBrief
Researchers cited a lack of evidence for the effectiveness of Otsuka Pharmaceutical and Bristol-Myers Squibb's Abilify as maintenance therapy for bipolar disorder. Only one randomized, double-blind clinical trial evaluated Abilify's long-term benefits, and that study had limitations, researchers no--
View full resource at smartbrief.com
Tags: Bipolar Disorder, Bipolar Disorder Medication, Schizophrenia Medication, Antipsychotic Medication, Disease and Condition, Abilify, Nursing Professions, Nurse
Most Recently Shared on May 4, 2011 at 3:33 pm By:
Advertisement
